JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258904

Human HMGN3 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

HMGN3 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon1.
1 Images
Sanger Sequencing - Human HMGN3 knockout HEK-293T cell lysate (AB258904)
  • Sanger seq

Unknown

Sanger Sequencing - Human HMGN3 knockout HEK-293T cell lysate (AB258904)

Homozygous : 2 bp deletion in exon1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258904-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human HMGN3 knockout HEK293T cell lysate", "number":"AB258904-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258904-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
HMGN3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HMGN3 also known as High Mobility Group Nucleosome-Binding Domain 3 is a protein that interacts with chromatin and influences its structure. It weighs approximately 10 kDa. HMGN3 is expressed in various tissues with high levels found in the brain pancreas and kidney. This protein regulates chromatin compaction impacting gene expression and cellular functions.
Biological function summary

HMGN3 functions by modulating the access of transcription factors to DNA. It is not a part of any known multi-protein complex but acts independently. By altering the chromatin landscape HMGN3 plays a role in the regulation of genes involved in metabolism and neurodevelopment impacting cellular processes like energy balance and synaptic function.

Pathways

HMGN3 participates in the insulin signaling and neurodevelopmental pathways. It influences the insulin signaling pathway by affecting genes that manage glucose metabolism. Related proteins include insulin receptor substrate 1 (IRS1) as they work together to ensure proper metabolic responses. In the neurodevelopmental context HMGN3 interacts with pathways involving the brain-derived neurotrophic factor (BDNF) contributing to the development and plasticity of neurons.

HMGN3 relates to type 2 diabetes and neurodegenerative diseases like Alzheimer's. The role of HMGN3 in glucose metabolism links it to type 2 diabetes alongside proteins like IRS1 that influence insulin resistance. In Alzheimer's disease HMGN3 might contribute to synaptic dysfunction interacting with BDNF and other neurotrophic factors signaling potential areas of therapeutic interest.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com